2 SWATH-mass spectrometry (MS) enables accurate and reproducible proteomic profiling in 3 multiple model organisms including the mouse. Here we present a comprehensive mouse 4 reference spectral library (MouseRefSWATH) that permits quantification of up to 10,597 5 proteins (62.2% of the mouse proteome) by SWATH-MS. We exploit MouseRefSWATH to 6 develop an analytical pipeline for species-specific deconvolution of proteomic alterations in 7 human tumour xenografts (XenoSWATH). This method overcomes the challenge of high 8 sequence similarity between mouse and human proteins, facilitating the study of host 9 microenvironment-tumour interactions from 'bulk tumour' measurements. We apply the 10 XenoSWATH pipeline to characterise an intraductal xenograft model of breast ductal 11 carcinoma in-situ and uncover complex regulation of cell migration pathways that are not 12 restricted to tumour cells but also operate in the mouse stroma upon progression to invasive 13 disease. MouseRefSWATH and XenoSWATH opens new opportunities for in-depth and 14 reproducible proteomic assessment to address wide-ranging biological questions involving 15 this important model organism. 16 17 18 19
Introduction 1
Mass spectrometry (MS) has become an essential tool for contemporary proteomic research 2 in life sciences. Conventional data-dependent acquisition (DDA) mode, where a fixed number 3 of the most abundant precursor ions in survey scans are automatically selected for 4 fragmentation, enables the identification of thousands of proteins in a single MS experiment. 5
However, the stochastic nature of precursor ion selection in DDA leads to low reproducibility 6 in peptide identification between experimental runs [1, 2] . Sequential window acquisition of all 7 theoretical mass spectra (SWATH-MS) or data-independent acquisition mass spectrometry 8 (DIA-MS) is a next-generation label-free quantification method that enables highly 9
reproducible peptide identification and more accurate quantification in large-scale proteomic 10 analyses across multiple experiments [3] [4] [5] . This method is based on the periodic 11 fragmentation of all precursor ions in wide and adjacent isolation windows that cover the entire 12 mass to charge ratio (m/z) range measured [3] . In this manner, all precursor ions generated 13 from the sample under investigation are fragmented and their fragmentation spectra acquired 14 for subsequent in silico analysis. These quantitative digital proteome maps have been shown 15 to have wide applications in medical research such as the discovery of potential biomarkers 16 and therapeutic targets [6] [7] [8] [9] [10] as well as tumour proteotyping for cancer stratification and 17 classification [11, 12] . 18 specific experimentally derived spectral libraries, this approach is time consuming and is prone 23 to wide variation between laboratories due to the lack of standardisation in DDA data 24 acquisition and library generation. Such variation results in study-specific bias and poor inter-25 laboratory reproducibility. The recent development of the algorithms that control for false 26 discovery rate (FDR) in SWATH-MS datasets has opened up the possibility of building large 27 reference spectral libraries that can be readily shared by the community, increasing data 28 reproducibility across laboratories and accelerating SWATH-MS experiments without the need 1 to generate study-specific spectral libraries [14, 15] . 2 3 Several such large reference spectral libraries have been built and deposited into repositories 4 such as SWATHAtlas (www.SWATHatlas.org) including libraries for human [15] , fruit fly [16] , 5 zebrafish [17] and yeast [18] . There is however currently no publically available 6 comprehensive mouse reference spectral library. The mouse as a model organism has and 7 continues to be extensively used in developmental biology and medical research due to the 8 complex genetics and physiological systems that mammals share. The array of innovative 9 genetic strategies available for engineering mice has revolutionised our understanding of 10 multiple human diseases including cancer, diabetes, autoimmune disease and heart disease 11 amongst others. Furthermore, immunocompromised mouse models have been used for more 12 than a decade as hosts for human tumour (both cell line and patient-derived) xenografts which 13 have served as an essential tool to investigate the factors that drive carcinogenesis as well as 14 to evaluate cancer therapeutics [19] . Developing a comprehensive mouse reference spectral 15 library will facilitate the application of SWATH-MS to address key research questions involving 16 this widely used model organism. A number of study-specific mouse spectral libraries have 17 previously been reported [20] [21] [22] [23] , for instance a spectral library that is comprised of the mouse 18 immunopeptidome containing 1573 peptides presented by MHC class I molecules [20] and a 19 spectral library reported by Williams et al. which is comprised of 5152 proteins (30% of mouse 20 proteome) generated from five organs [21] . Notably, in the aforementioned human tumour 21 xenograft models, there is currently no established method to deconvolute host (mouse) 22 versus tumour (human) proteomic alterations from 'bulk tumour' proteomes which has limited 23 our ability to study the role of the tumour microenvironment in driving tumour initiation and 24 progression. 25
26
In this study, we present a comprehensive mouse reference spectral library 27 (MouseRefSWATH) generated from 15 distinct mouse organs and cellular samples. 28
MouseRefSWATH was built from 254 individual MS experiments and is composed of 1 transitions for 167,138 proteotypic peptides from 10,597 proteins representing 62.2% of 2 manually validated mouse protein-encoding genes (Swissprot database). The performance of 3
MouseRefSWATH was evaluated in two publicly available SWATH-MS datasets which 4 showed both qualitative and quantitative reproducibility when compared to published study-5 specific spectral libraries. We further report the development of a novel application of 6
MouseRefSWATH for SWATH-MS-based mapping of species-specific temporal proteomic 7 alterations in an orthotopic tumour xenograft model of breast ductal carcinoma in situ (DCIS). 8
Utilising this approach, we reveal for the first time, simultaneous temporal regulation of cell 9 migration pathways in both the host mouse mammary gland and human tumour cells during 10 the course of DCIS to invasive breast cancer (IBC) progression. This XenoSWATH pipeline 11 for species-specific deconvolution of 'bulk tumour' proteomics data provides a useful tool with 12 broad applications for the analysis of host microenvironment-tumour interactions in xenograft 13 models without the need for prior separation of host and tumour cell populations. The MS raw 14 data and MouseRefSWATH spectral library for this study is available via ProteomeXchange 15 with identifier PXD017209. 16
17
Results 18
Proteomic analysis of murine tissue and cells. 19
To maximize coverage of the mouse proteome in the reference spectral library, we performed 20 DDA proteomic analysis of a comprehensive range of 7 murine organs comprising heart, brain, 21 lung, liver, kidney, lymph node and mammary gland ( Figure 1 and Table 1 ). In addition, we 22 undertook proteomic profiling from primary CD8 + T-lymphocytes (non-stimulated and 23 activated) as well as immortalised murine cell lines including normal (NF1) and cancer-24 associated (CAF1) fibroblasts [24] and commercially available cell lines NIH-3T3, C2C12, 4T1 25
and Ba/F3 of diverse tissue origin (Table 1) . As outlined in the workflow shown in Figure 1 , 26 extracted proteins from each sample type were digested by trypsin and the resulting peptide 27 mixture was subjected to offline fractionation in the first dimension either by strong cation 28 exchange (SCX) chromatography or reverse phase chromatography in high pH (HpH-RP) 1 (Table 2) . To calibrate the chromatographic retention time for individual DDA runs, prior to 2 liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis each fraction was 3 spiked with the iRT calibration standard that contains mixture of 11 synthetic peptides [13, 25] . 4
Peptides from each fraction were subsequently analysed by LC-MS/MS in DDA mode and the 5 acquired data were processed by SpectroMine [26, 27] . An average of between 3200-6600 6 proteins were identified across the different samples as shown in Table 2 . 7 8 Building the MouseRefSWATH spectral library 9
We built the mouse reference spectral library (MouseRefSWATH) from the datasets listed in 10 Table 2 by employing the SpectroMine software ( Figure 1 ). Only unique protein-specific 11 (proteotypic) peptides were used to generate the library which comprise 10,597 proteins 12 ( Figure 2A ), representing 62.2% coverage of manually annotated mouse protein-coding genes 13 (Swissprot, 26/10/2018). Comparative analysis demonstrates a superior proteome coverage 14 versus published spectral libraries of other higher eukaryotic organisms (human -51% [15] 15 and zebrafish -40.4% [17]) ( Figure 2B ). Figure 2C shows the distribution of unique peptides 16 per protein group with 90.6% of proteins represented by >1 unique peptide in the spectral 17 library and 46.7% of proteins being represented by >10 unique peptides. The contribution plot 18 ( Figure 2D ) shows that 1949 proteins (18.4%) in the MouseRefSWATH library were detected 19 in all analysed sample types used in the generation of the library. The brain contributed the 20 highest number of proteins (551, 5.2%) to the MouseRefSWATH library, followed by T cells 21 (165, 1.6%) and lung (127, 1.2%). 22
23

Evaluating the performance of the MouseRefSWATH spectral library 24
To demonstrate the utility of the MouseRefSWATH library and benchmark its performance 25 against study-specific libraries generated as part of published SWATH-MS studies, we applied 26 the reference spectral library to 2 publicly available SWATH-MS datasets focused on 27 mitochondrial [21] and hippocampal [22] proteins ( Figure 1 ). Each dataset was analysed using 28 either the original study-specific library generated by the authors or the MouseRefSWATH 1
library. 2 3
In a recent mitoproteome study undertaken by Williams et al. [21] , a study-specific library 4 based on DDA analysis of both total tissue lysates and mitochondria-enriched samples was 5 utilised. We sought to assess the extent to which the MouseRefSWATH library was able to 6 both qualitatively and quantitatively recapitulate the data generated by the study-specific 7 library in the published study. The SWATH-MS data of mitochondrial proteins was downloaded 8 from ProteomeXchange (PXD005044) and analysed using both libraries ( Figure 2E & F). The 9
Williams et al. experimental dataset was generated from mitochondria enriched from 5 distinct 10 murine tissues (brown adipose tissue (BAT), heart, liver, quadriceps, brain,) from 5-8 animals. 11
Qualitatively, the MouseRefSWATH library identified 91.1% (640 proteins) of the 12 mitoproteome ( Figure 2E ) found using the study-specific library with an additional 26 proteins 13 identified specifically by the MouseRefSWATH library. An assessment of the quantification of 14 the 640 overlapping proteins showed a good correlation between both libraries with Pearson's 15 correlation coefficient r values ranging between 0.92 -0.95 ( Figure 2F ). 16
17
We undertook a similar comparative analysis on the study by von Ziegler et al. [22] where the 18 basal mouse hippocampal proteome was analysed utilising a study-specific spectral library 19 built from DDA data generated from the mouse hippocampus. For this analysis, the SWATH-20 MS experimental data of hippocampal area CA1 and CA3 from 6 different animals were 21 analysed ( Figure 2G & H). The MouseRefSWATH library identified 80.2% (943 proteins) of 22 hippocampus proteome found using the study-specific spectral library ( Figure 2G ). The 23
MouseRefSWATH library further identified 211 more proteins compared to the hippocampus-24 specific spectral library. Good correlation in protein quantification between the 25
MouseRefSWATH and study-specific library for the overlapping 943 proteins was observed 26 with Pearson's correlation coefficient r values ranging between 0.78-0.81 across the 6 mice in 27 the experiment ( Figure 2H ). Taken together, our analysis demonstrates that applying the 28 MouseRefSWATH to SWATH-MS datasets is routinely able to identify >80% of proteins 1 identified using study-specific libraries with comparable quantification, highlighting its broad 2 utility as a general reference library applicable for use in multiple mouse SWATH-MS datasets 3 without the need to generate study-specific libraries. Mouse xenograft studies are one of the cornerstones of modern cancer research where 8 human tumour cells are typically grafted into a mouse host either subcutaneously or 9 orthotopically as a means to evaluate oncogene and tumour suppressor gene function or 10 investigate the therapeutic effects of drugs [28, 29] . In these models, there are complex 11 interactions between the human tumour cells and the host microenvironment which play 12 important roles in driving cancer progression and therapy response [30] [31] [32] . There is currently 13 no means to distinguish proteins of human and mouse origin from 'bulk tumour' proteomics 14 data generated by SWATH-MS, which presents a key barrier in our ability to undertake deep 15 characterisation of mechanisms of tumour-microenvironment interactions in vivo. Previous 16 studies have attempted to tackle this challenge by separating human tumour and murine host 17 cells utilising immunoaffinity cell enrichment strategies prior to MS analysis [33] . However, 18 such methods are labour intensive, introduce sample preparation biases and disrupt the in 19 situ architecture and cellular interactions important for driving tumour biology. 20
21
To address this challenge, we developed a novel pipeline (XenoSWATH) to deconvolute 22 species-specific proteomic profiles from SWATH-MS data obtained in mouse xenograft 23 experiments. In this XenoSWATH workflow (Figure 3 ), both the MouseRefSWATH library as 24 well as a previously published pan-Human reference library [15] were used in the Spectronaut 25 software [14] . In the first step of data processing, peptides were identified by searching the 26 acquired SWATH-MS data against either the MouseRefSWATH or pan-Human library. Both 27 libraries contain proteotypic peptides which can distinguish individual proteins, however given 28 that humans and mice share ~70% of protein coding sequences [34] , not all of these 1 proteotypic peptides are also species-discriminating. Therefore to selectively quantify human 2 and mouse proteins from 'bulk tumour xenograft' proteomic datasets, we focused on peptides 3 that are both protein-and species-discriminating (see Figure 3 for example). To achieve this, 4 rather than using individual FASTA files comprising in silico digested peptides for either human 5 or mouse proteins, we instead manually combined both files into a single FASTA file for 6 peptide quantification. This modification to the data processing pipeline enables Spectronaut 7 to compare sequences of the identified peptides from either the mouse or human reference 8 spectral library with the sequences of the in silico digested peptides within the combined 9 FASTA file; and filter out any peptides that are shared between human and mouse. This leads 10 to the retention of only peptides that are both proteotypic and species-discriminating for 11 peptide quantification. The resultant output from this XenoSWATH pipeline is two datasets -12 one comprising entirely of murine proteins and the other of human proteins. 13
14
SWATH-MS analysis and deconvolution of tumour (human) and host mammary gland (mouse) 15 proteomic alterations in a xenograft model of DCIS progression. 16
We applied the XenoSWATH deconvolution pipeline to quantify the species-specific proteomic 17 alterations associated with DCIS progression to IBC in an orthotopic mouse intraductal breast 18
DCIS (MIND) xenograft model. The MIND model is based on the injection of human breast 19
DCIS cells such as the MCF10DCIS.com cell line into the mouse mammary duct ( Figure 4A ) 20 [35] [36] [37] . Compared to the other breast cancer xenograft models such as mammary fat pad 21 injection, the MIND model has been shown to better recapitulate the mammary gland 22 microenvironment [36], a key regulator of breast cancer progression [31, 38] , and is therefore 23 a more clinically relevant model for this disease. In our experiments, MCF10DCIS.com-Luc 24 cells were injected intraductally into the mammary glands of mice where they form tumours 25 that faithfully model the process of DCIS progression over the course of 10 weeks ( Figure 4B -26 D) [35] . Tumours at 4 weeks post injection (referenced as 4w, number of biological replicates 27 n=7) mimic non-invasive DCIS lesions, while after 6 weeks of growth (6w, n=7), tumours start 28 microinvading into the surrounding tissue and finally progress to full IBC at 10 weeks (10w, 1 n=8) post injection ( Figure 4D ). There is a significant increase in size of the 10w lesions 2 compared to the 4w (p=0.0012) and 6w (p=0.0059) lesions but no significant difference in 3 tumour size between 4w and 6w lesions (p=0.317) ( Figure 4B -C) when most lesions at 6w 4 remain within the duct and only a few cells are microinvading out of the ducts. 5 6 Whole mammary glands with tumour (n=4) were collected after 4, 6 and 10 weeks post 7 injection and subjected to SWATH-MS analysis ( Figure 4A ). When processed through the 8 XenoSWATH pipeline (Figure 3 ), we successfully quantified 2,086 murine and 1,177 human 9 proteins in all samples across the three time-points (Table S1 ). Our analysis showed no 10 significant differences in protein expression levels in both human and murine datasets 11 between the 4w and 6w specimens, indicating that the non-invasive DCIS lesions (4w) and 12 tumours with microinvasion (6w) harbour similar proteomic profiles at this level of resolution. 13
Comparing the 4w and 6w data with the 10w lesions led to the identification of 327 murine and 14 247 human proteins that showed significant changes in protein expression (Table S2) . 15
16
Gene set enrichment analysis (GSEA) was performed to identify functional ontologies that 17 were enriched in the murine and human proteomic datasets upon DCIS progression to IBC 18 ( Figure 4E and Table S3 ). This analysis showed a number of ontology networks that were 19 almost exclusively enriched in either in the human tumour cells (cell death & apoptosis, protein 20 localisation to membrane and epithelial cell development) or the mouse stroma (cell adhesion, 21 actin filament organisation and innate immune response) ( Figure 4F ). Notably, we identified 22 16 overlapping ontologies that were upregulated in both species, the majority of which were 23 associated with increased cell migration ( Figure 4E-F ). An assessment of the upregulated 24 proteins in a subset of these overlapping ontologies revealed a complex regulation of protein 25 networks in both the human and mouse compartments. For instance, within the networks 26 regulating cell motility and locomotion ( Figure 4F ), specific proteins were upregulated in the 27 tumour cells only [e.g macrophage inhibitory factor (MIF) and peptidylprolyl isomerase A 28 (PP1A)], host cells only [e.g. S100a8 and S100a9]; or in both compartments [e.g. Galectin-3 1 (LGALS3), Fibronectin (FN1), Ezrin (EZR), CD44 antigen (CD44)]. Employing the 2 deconvolution pipeline, our analyses demonstrates for the first time that the temporal 3 upregulation of cell migration pathways consistent with DCIS to IBC progression is not 4 restricted only to the tumour cells but is found to also operate in the host tumour 5 microenvironment. This proof-of-principle experiment demonstrates the utility of our 6
XenoSWATH deconvolution pipeline for the comprehensive mapping of temporal alterations 7 in the tumour versus host proteome in tumour xenograft models and its ability to capture 8 relevant tumour biology for subsequent investigation. 9
10 Discussion 11
In this study, we have built the first comprehensive mouse reference spectral library 12 (MouseRefSWATH) for SWATH-MS applications. The MouseRefSWATH library is generated 13 from proteomic datasets acquired across wide range of murine tissue samples, primary cells 14 and cell lines which facilitates versatile use in proteomic profiling of various sample types. We 15 demonstrate its utility in two publicly available SWATH-MS datasets where the use of 16
MouseRefSWATH identified and accurately quantified >80% of the proteins compared to 17 study-specific libraries with a Pearson's correlation coefficient for protein quantification of at 18 least 0.78. In both datasets, the MouseRefSWATH library further identified new proteins which 19 would have otherwise not been possible with study-specific libraries. In addition to removing 20 the need to generate study-specific libraries for future murine SWATH-MS experiments, the 21 benefits of utilising the larger MouseRefSWATH library include the fact that individual proteins 22 are represented by a higher number of precursor ions resulting in better accuracy and higher 23 confidence in protein quantification. 24
25
We have also extended the use of the MouseRefSWATH library and developed a novel 26 analysis pipeline called XenoSWATH that enables deconvolution of murine and human 27 proteins from 'bulk tumour' xenograft proteomic measurements through the identification of 28 species-discriminating proteotypic peptides. The lack of tools to perform a deep analysis of 1 tumour (human) and host (mouse) molecular alterations in situ have limited our ability to study 2 the role of the tumour microenvironment in driving tumour progression. In silico approaches 3 have been developed to deconvolute mouse and human reads in next generation DNA and 4
RNA sequencing data derived from tumour xenografts but such approaches do not yet exist 5
for proteomic data analysis [39] . The only published application of SWATH-MS in a xenograft 6 model thus far has focused on measuring the murine stromal component by pre-enrichment 7 of mouse cells with immunoaffinity chromatography while completely omitting the human 8 tumour cells [33] . XenoSWATH presents a paradigm shift in the ability to distinguish and 9 comprehensively map proteomic alterations in both the human and mouse compartments and 10 provides a new approach to investigating tumour cell-microenvironmental interactions in 11 cancer initiation, progression and therapy response. With the recent development of human 12 tumour xenograft models in immunodeficient zebrafish [40] , we anticipate that XenoSWATH 13 can be readily extended to the study of host and tumour cell responses in these models by 14 similarly utilising the zebrafish reference spectral library available in SWATHAtlas [17] . 15
16
As proof-of-principle, we undertook a quantitative proteomic analysis in the MIND model and 17 provide the first characterisation of host stroma and tumour cell proteomic alterations that 18 occur during DCIS to IBC progression. Our analysis reveal complex network alterations in both 19 compartments, and while the human tumour cells show an expected upregulation of migration 20 pathways during progression to invasive disease, we make the unanticipated discovery that 21 the mouse stroma also displays an enrichment of cell migration and motility networks upon 22 DCIS progression. In the mouse dataset, the highest observed increase in migration-23 associated protein expression levels between early (4w & 6w) versus late (10w) timepoints 24 were in the S100a8 and S100a9 proteins (Table S2 ). These two proteins together form the 25 calprotectin complex and stromal cells secreting calprotectin have been previously observed 26 in the microenvironment of pancreatic cancer [41] . Additionally S100a8 has been reported to 27 increase the migration and proliferation of colorectal and pancreatic cancer cells in vitro [41] 28 and has also been associated with metastasis formation in breast cancer [42] . MIF was found 1 to be exclusively upregulated in the human DCIS.com cells at 10 week post-injection but not 2 in the mouse stromal cells. Increased levels of MIF has been reported in many cancer types 3 including pancreatic cancer [43] , hepatocellular cancer [44] or head and neck cancer [45] . 4
Experiments with murine breast cancer cell line 4T1 have shown that overexpression of MIF 5 promotes tumour metastasis [46] and protects cancer cells from immunogenic cell death [47] . 6
Finally, we determine that LGALS3, CD44, FN1 and EZR were upregulated in both tumour 7 and host datasets. These proteins have been extensively shown in published literature to 8 regulate cytoskeleton remodelling, epithelial-mesenchymal transition and increased cell 9 motility [48] [49] [50] , all of which are important in breast cancer progression to invasive disease. 10
These examples highlight the utility of this deconvolution pipeline in dissecting the individual 11 roles of the tumour cells and the associated stroma in cancer biology. This dataset serves as 12 a rich resource of tumour and microenvironmental proteins for future functional investigation, 13 candidate biomarkers for stratifying DCIS patients with increased risk of progressing to IBC, 14 as well as targets for drug discovery for delaying DCIS progression. 15
There are several limitations to the XenoSWATH pipeline. Because the method focuses on 17 quantifying peptides that are both proteotypic and species-discriminating, a significant number 18 of proteins with high sequence similarity between mouse and human are filtered out and lost 19 during the process, resulting in the quantification of a reduced subset of the proteome. Despite 20 this limitation, we are still able to readily identify key pathways that are operating in both the 21 human and mouse compartment. Given that the stroma is composed of a number of different 22 cell types including fibroblasts, endothelial cells and immune cells; as with other population-23 level based measurement methodologies, the XenoSWATH pipeline is unable to resolve the 24 individual contribution of specific stromal cell types to the aggregate proteomic data. Extending 25 in silico transcriptomic deconvolution strategies that are currently being used to estimate 26 stromal cell types to proteomic data may provide better resolution and address this 27 shortcoming in future [51] . 28
Collectively, our study has generated the MouseRefSWATH comprehensive mouse reference 1 spectral library as a standardised community resource for use in future mouse SWATH-MS 2 studies, which will not only remove the need for the generation of study-specific libraries but 3 will also improve inter-laboratory reproducibility. We further present a new XenoSWATH 4 analysis pipeline for species-specific deconvolution of xenograft proteomic data which opens 5 new possibilities for the in-depth assessment of tumour-host interactions in murine xenograft 6 models. Moving forward, we anticipate that these tools will have broad applications in 7
addressing key biological research questions involving this widely used model organism. dissected from 14-week-old to 18-week-old virgin female SCID Beige mice. Brain, heart and 16 kidney organs were dissected from 6 months old female NCR nude mice. Lymph nodes were 17 dissected from 2-4 months old C57BL/6N male and female mice. All tissue specimens were 18 briefly washed in cold phosphate-buffered saline (PBS) to remove excess blood and 19 immediately snap frozen in liquid nitrogen and stored at -80 ºC. 20 21 Primary CD8+ effector T-cells were isolated from splenocytes of OT-I mice and cultured in 22
Roswell Park Memorial Institute (RPMI) medium with 10% foetal bovine serum (FBS) (Gibco), 23 1% penicillin-streptomycin and 0.1% β-mercaptoethanol. In order to activate OT-I CD8 + T-24 cells, OT-I splenocytes were treated with 1 μg/ml OVA257-264 peptides in the presence of 10 25 ng/ml IL-2 for 3 days while the non-stimulated resting CD8 + T-cells were collected after 26 culturing with IL-2 alone. Immortalized normal (NF1) and cancer-associated fibroblasts (CAF1) 27
[24] were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% 28 FBS, 1x GlutaMAX (Gibco), 0.5% penicillin-streptomycin and 1x insulin-transferrin-selenium 1 A (ITS-A) (Gibco). NIH-3T3 cells were cultured in DMEM supplemented with 10% 2 FBS/100units/ml penicillin/100mg/ml streptomycin. C2C12 and 4T1 cells were cultured in 3 RPMI supplemented with 10% FBS/100units/ml penicillin/100mg/ml streptomycin. Ba/F3 cells 4 were cultured in the same media as 4T1 cells with the addition of 5ng/ml IL-3. All cells were 5 cultured in 95% air/5% CO2 atmosphere at 37°C. Dried peptides were resuspended in 100 µl of buffer SCX-A consisting of 10mM NH 4 COOH 8 (Sigma) in 20% acetonitrile (Thermo Fisher), pH 2.7, vortexed, sonicated for 5 min and spun 9 at 15,000 rpm for 1 min. The supernatant was loaded on a 2.1 x 100 mm Polysulfoethyl A 10 column with 5 µm, 200 Å particles (PolyLC Inc.) and eluted with buffer SCX-B (500mM 11 NH 4 COOH in 20% acetonitrile, pH 2.7) using a gradient of 0-10% of B in 2.5 min, 10-50% of 12 B in 20 min, 50-100% of B in 7.5 min and 100% of B for 10 min. Twelve fractions were manually 13 collected over 39 min with fraction 1 collected from 0 to 12 min and fraction 12 from 32 to 39 14 min. The remaining 10 fractions were collected at 2 min intervals between 12 to 32 min. All 15 SCX fractions were dried in a SpeedVac concentrator. 16 17
Fractionation by high pH reverse phase (HpH RP) chromatography 18
Dried peptides were resuspended in 100 µl of buffer HpH-A (0.1% NH 4 OH), vortexed, 19 sonicated for 5 min and spun at 15,000 rpm for 1 min. The supernatant was loaded on a 2.1 20
x 150 mm XBridge BEH C18 column with 5 µm, 130 Å particles (Waters) and eluted with buffer 21
HpH-B (0.1% NH 4 OH in acetonitrile) using a linear gradient of 0-50% B over 60 min. Fractions 22 were automatically collected between 5 and 50 min every 30 s into 96 well plate and fractions 23 were pooled into 12 fraction (columns pooled) for 3T3 cells or 8 fractions (rows pooled) for 24 4T1, BaF3 and C2C12 cells. Pooled fractions were dried in a SpeedVac concentrator. 25 26 27 28
DDA MS data acquisition 1
All fractions were resuspended in 20 µl of buffer A (2% acetonitrile, 0.1% formic acid) and 2 peptide concentration was measured using the 280 nm NanoDrop assay. 1 µg of total peptide 3 was analysed in DDA mode on an Agilent 1260 HPLC coupled to a TripleTOF 5600+ mass 4 spectrometer equipped with NanoSource III. Each fraction was spiked with 0.1 µl of iRT 5 calibration mix (Biognosys, AG) and loaded onto a 0.3 x 5 mm ZORBAX C18 (Agilent Search Archives of all datasets were combined in SpectroMine and the MouseRefSWATH 28 reference spectral library was built using following the parameters: minimum 3 and maximum 1 6 transitions for each precursor, library-wide protein and peptide FDR threshold of 1%. The library. Using the combined FASTA file, Spectronaut selects only the mouse species 1 discriminating proteotypic peptides from the MouseRefSWATH library for the quantification of 2 murine proteins. The same approach was repeated with pan-Human library for the 3 quantification of human species discriminating proteotypic peptides. All searches were 4 performed with 1% FDR threshold on peptide and protein level (detailed Spectronaut settings 5 are shown in Supplementary methods). In this manner, two separate proteomic datasets were 6 obtained, one for the tumour component (human) and the other for the host stromal 7 compartment (mouse). The datasets were separately quantile normalized using proBatch The 'bulk tumour xenograft' acquired SWATH-MS data is first subjected to two separate searches by either the MouseRefSWATH or the pan-Human library in the Spectronaut software to identify protein-specific (proteotypic) peptides. A combined FASTA file of human and mouse in silico digested peptides is then generated to enable subsequent peptide quantification of species-discriminating proteotypic peptides. For peptide quantification, Spectronaut will compare the sequences of the identified peptides from either the MouseRefSWATH or pan-Human library searches with the peptides sequences in the combined FASTA file. Because protein-specific (proteotypic) peptides that are not speciesdiscriminating (blue) occur more than once in the combined FASTA file, Spectronaut filters these peptides out. Only peptides which are both protein-specific and species-discriminating (purple for mouse and green for human) in the combined FASTA file are retained and subjected to quantification. The output of this pipeline is two quantified datasets, one specific for mouse proteins and the other for human proteins. .com-Luc cells were injected orthotopically into mouse mammary gland ducts through the nipple. Whole mammary glands with tumours were removed at 4, 6 and 10 weeks (w) post-injection and subjected to sample preparation prior to SWATH-MS data acquisition and analysis by the XenoSWATH pipeline. B) Representative bioluminescence images as measured by IVIS at 4, 6 and 10w post-injection. C) Total bioluminescence flux reflecting tumour size in MIND model at 4, 6 and 10w post-injection (n=7-8). p-value represents statistical significance of the difference between the sample groups calculated by two-tailed Mann-Whitney test. D) H&E images showing initial DCIS lesion formation in the MIND model at 4w which progresses to form an invasive tumour at 10w postinjection. Tumour microinvasion in lesion 10w post-injection is indicated by arrowheads. E) Venn diagram showing the overlap of enriched ontologies for proteins that are significantly upregulated in the 10w specimens versus the 4 and 6w specimens as identified by GSEA with FDR<0.1. Ontologies associated with cell motility, migration and cytoskeleton organization are highlighted in red. F) Network depicting ontologies enriched in human (purple) and mouse (green) datasets (10w versus 4w and 6w) and their overlap as identified by GSEA. Detailed protein networks for two selected ontologies (cell motility and locomotion) are shown. In these networks, the protein node border colour represents the mouse dataset while the protein node fill colour represents the human dataset. Proteins that are not detected are represented by grey. Table S1 : Full proteomic dataset of human and mouse proteins obtained from MIND model experiment as processed by XenoSWATH deconvolution pipeline. Confidence of the protein identification is reported as FDR value. Week 6 Week 10 
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